Report Code: A03782 | Nov 2023 | Pages: NA | ||
Tables: NA | Charts: NA |
|
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the Heart Failure Diagnostics/therapeutics Market
Request Now !Heart failure or congestive heart failure is a phenomenon, which occurs when the heart muscle is not able to pump blood properly or when it leads to conditions such as high blood pressure, high cholesterol level, narrowing of blood vessels, and others. Heart failure diagnosis can be done by various ways such as blood tests, electrocardiogram chest x-ray, echocardiogram, and others.
Growth in incidence of heart failure, rise in incidence of diabetes, atherosclerosis, stroke, hypertension, and other conditions, technological advancements in cardiac heart failure treatment devices, sedentary lifestyle habits, and growth in geriatric population drive the market growth. However, reimbursement issues and high cost of diagnosing devices in the emerging countries are some of the factors that restrict the market growth. Moreover, new emerging technologies of cardiovascular treatment & diagnostics generate numerous opportunities in untapped markets in the near future.
The market is segmented on the basis of therapy, product, tests, and region. On the basis of therapy, it is divided into cardiac resynchronization therapy, ventricular assist devices, counterpulsation implants, heart failure surgery, fluid reduction, neurostimulation, hemodynamic monitoring, and central sleep apnea. On the basis of product, it is classified into electrocardiogram systems, holter monitors, event monitors, and implantable loop recorders.
On the basis of tests, it is categorized into electrocardiogram, blood tests, troponin, CK-MB, and others. By geography, the market is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, UK, France, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).
The key players profiled include Abbott Laboratories, Beckman Coulter, Abiomed Inc., Berlin Heart GmbH, Biotronik SE & Co. KG, Boston Scientific Corporation, HeartWare International Inc., Jarvik Heart Inc., Medtronic plc, and St. Jude Medical.
Key Benefits
Heart Failure Diagnostics/Therapeutics Market Report Highlights
Aspects | Details |
---|---|
By Therapy |
|
By Product |
|
By Tests |
|
By Region |
|
Key Market Players | St. Jude Medical., Abiomed Inc., Abbott Laboratories, Medtronic plc, Beckman Coulter, Berlin Heart GmbH, Jarvik Heart Inc., Biotronik SE and Co. KG, Boston Scientific Corporation, HeartWare International Inc. |
Start reading.
This Report and over 66,944+ more Reports, Available with Avenue Library. T&C*.
Enterprise
License/PDF
Library
Membership
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
Get Industry Data AlertsTo ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers